A Study to Investigate the Safety and Immunogenicity of the SF2a-TT15 Synthetic Carbohydrate-based Conjugate Vaccine Against Shigella Flexneri 2a
Clinical trial NCT04602975 · COMPLETED
Trial details
- NCT number
- NCT04602975
- Sponsor
- Institut Pasteur
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-06
- Primary completion
- 2023-04-12
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.